However, more knowledge of T-cell responses induced by these vaccine regimens may be of future relevance for vaccines currently in early development, such as those designed to induce broadly neutralizing antibodies (bNAbs), as it has been demonstrated that bNAbs work synergistically with CD8+ effector T cells to suppress infection (36). The gene discussed is CD8A; the disease is infection.